NEW YORK (AVAFIN) -- A record number of BioMarin Pharmaceutical call contracts were traded during the busy trading session. There
were 1.6 call contracts traded for each put contract yielding a 0.62 put/call ratio
where 3,351 put and 5,399 call contracts exchanged hands.
Options can be used as predictors of stock behavior. Investors can use put/call ratios as
technical indicators to read for signs of institutional sentiment. The put/call ratios
offer insight to investors and can be used as either a direct or contrarian indicator
for trading decisions. Unusual volume provides reliable clues that the stock is expected
to make a move.
Shares of BioMarin Pharmaceutical settled at $49.58, up $1.28 (+2.65%) in the last trading session.
The shares of the stock had an intraday low of $48.05 and high of $49.73. To date, the stock has lost -0.80% within the last week.
The stock's 52 week low is $30.98 and 52 week high is $52.96.
View Best Performing Stocks
